Allstate Corporation (The) (NYSE:ALL) – Equities research analysts at FBR & Co lowered their Q2 2017 EPS estimates for Allstate Corporation (The) in a research report issued to clients and investors on Tuesday. FBR & Co analyst R. Binner now expects that the insurance provider will earn $1.04 per share for the quarter, down from their previous estimate of $1.28. FBR & Co currently has a “Mkt Perform” rating and a $82.00 target price on the stock. FBR & Co also issued estimates for Allstate Corporation (The)’s FY2017 earnings at $6.25 EPS.

Other analysts have also recently issued reports about the company. BidaskClub cut Allstate Corporation (The) from a “strong-buy” rating to a “buy” rating in a report on Wednesday. Barclays PLC reduced their price target on Allstate Corporation (The) from $101.00 to $92.00 and set an “overweight” rating on the stock in a report on Monday, July 3rd. Wells Fargo & Company reiterated a “buy” rating on shares of Allstate Corporation (The) in a report on Saturday, June 24th. Credit Suisse Group set a $86.00 target price on Allstate Corporation (The) and gave the company a “hold” rating in a report on Saturday, March 25th. Finally, Keefe, Bruyette & Woods reiterated a “hold” rating and issued a $88.00 target price on shares of Allstate Corporation (The) in a report on Friday, June 16th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have assigned a buy rating to the company. Allstate Corporation (The) presently has an average rating of “Buy” and a consensus target price of $87.00.

ILLEGAL ACTIVITY WARNING: “Brokers Issue Forecasts for Allstate Corporation (The)’s Q2 2017 Earnings (ALL)” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The original version of this piece can be viewed at https://www.thecerbatgem.com/2017/08/08/brokers-issue-forecasts-for-allstate-corporation-thes-q2-2017-earnings-all-updated-updated-updated.html.

Allstate Corporation (ALL) opened at 88.20 on Thursday. The company has a market cap of $32.15 billion, a price-to-earnings ratio of 14.95 and a beta of 1.10. The stock has a 50 day moving average of $86.83 and a 200 day moving average of $80.91. Allstate Corporation has a 52 week low of $66.55 and a 52 week high of $90.74.

Allstate Corporation (The) (NYSE:ALL) last issued its earnings results on Wednesday, May 3rd. The insurance provider reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.60. The company had revenue of $9.30 billion for the quarter, compared to analyst estimates of $8.36 billion. Allstate Corporation (The) had a net margin of 6.27% and a return on equity of 11.45%.

The company also recently announced a quarterly dividend, which will be paid on Monday, October 2nd. Stockholders of record on Thursday, August 31st will be given a dividend of $0.37 per share. This represents a $1.48 dividend on an annualized basis and a dividend yield of 1.68%. The ex-dividend date of this dividend is Tuesday, August 29th. Allstate Corporation (The)’s payout ratio is 25.00%.

In other news, insider Sanjay Gupta sold 16,798 shares of the company’s stock in a transaction that occurred on Thursday, May 25th. The stock was sold at an average price of $86.00, for a total transaction of $1,444,628.00. Following the transaction, the insider now directly owns 65,798 shares of the company’s stock, valued at $5,658,628. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, President Matthew E. Winter sold 33,956 shares of the company’s stock in a transaction that occurred on Monday, April 17th. The stock was sold at an average price of $81.01, for a total value of $2,750,775.56. The disclosure for this sale can be found here. Insiders have sold 165,157 shares of company stock worth $14,191,466 over the last ninety days. 1.58% of the stock is owned by insiders.

Several institutional investors have recently modified their holdings of the company. FNY Partners Fund LP purchased a new position in shares of Allstate Corporation (The) during the first quarter worth $122,000. Bronfman E.L. Rothschild L.P. raised its stake in Allstate Corporation (The) by 8.5% in the first quarter. Bronfman E.L. Rothschild L.P. now owns 1,550 shares of the insurance provider’s stock worth $126,000 after buying an additional 122 shares during the last quarter. Oakworth Capital Inc. raised its stake in Allstate Corporation (The) by 505.8% in the first quarter. Oakworth Capital Inc. now owns 1,775 shares of the insurance provider’s stock worth $145,000 after buying an additional 1,482 shares during the last quarter. Howard Hughes Medical Institute bought a new stake in Allstate Corporation (The) during the first quarter worth approximately $160,000. Finally, Watermark Asset Management Inc. bought a new stake in Allstate Corporation (The) during the first quarter worth approximately $170,000. 76.27% of the stock is currently owned by institutional investors.

Allstate Corporation (The) Company Profile

The Allstate Corporation (Allstate) is a holding company for Allstate Insurance Company. The Company’s business is conducted principally through Allstate Insurance Company, Allstate Life Insurance Company and other subsidiaries. It is engaged in the property-liability insurance business and the life insurance, retirement and investment products business.

Earnings History and Estimates for Allstate Corporation (The) (NYSE:ALL)

Receive News & Stock Ratings for Allstate Corporation (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate Corporation (The) and related stocks with our FREE daily email newsletter.